Common use of Adequate Information Clause in Contracts

Adequate Information. The Investor has received from the Issuer, and has reviewed, such information as the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation the SEC Reports and recent press releases of the Issuer. The Investor acknowledges that each of the SEC Reports, including the risk factors contained therein, are specifically incorporated herein by reference and form an integral part of this Agreement.

Appears in 3 contracts

Samples: Stock Purchase Agreement (Axesstel Inc), Stock Purchase Agreement (Axesstel Inc), Stock Purchase Agreement (Axesstel Inc)

AutoNDA by SimpleDocs

Adequate Information. The Investor has received from the Issuer, and has reviewed, such information as which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation Shares and Warrants. The Investor also acknowledges that the additional risk factors set forth on Exhibit B and contained in the SEC Reports and recent press releases of the Issuer. The Investor acknowledges that each of the SEC Reports, including the risk factors contained therein, are specifically incorporated herein by reference and form an integral part of this Agreement.

Appears in 2 contracts

Samples: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)

Adequate Information. The Investor has received from the Issuer, and has reviewed, such information as which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation limitation, the SEC Reports and recent press releases of the IssuerReports. The Investor acknowledges that each of the SEC Reports, including the risk factors contained therein, Reports are specifically incorporated herein by reference and form an integral part of this Agreement. The Investor also acknowledges that the risk factors contained in the SEC Reports are specifically incorporated herein by reference and forms an integral part of this Agreement.

Appears in 2 contracts

Samples: Subscription Agreement (CDSS Wind Down Inc), Subscription Agreement (CDSS Wind Down Inc)

Adequate Information. The Investor has received from the Issuer, and has reviewed, such information as which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation . The Investor also acknowledges that the additional risk factors set forth on Exhibit D and contained in the SEC Reports and recent press releases of the Issuer. The Investor acknowledges that each of the SEC Reports, including the risk factors contained therein, are specifically incorporated herein by reference and form an integral part of this Agreement.

Appears in 2 contracts

Samples: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)

Adequate Information. The Investor has received from the Issuer, and has reviewedhad the opportunity to review, such information as which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation Shares and Warrants. The Investor also acknowledges that the risk factors set forth on Exhibit C and contained in the SEC Reports have been delivered to the Investor and recent press releases of the Issuer. The Investor acknowledges that each of has had the SEC Reports, including the opportunity to review such risk factors contained therein, are specifically incorporated herein by reference and form an integral part of this Agreementfactors.

Appears in 2 contracts

Samples: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)

Adequate Information. The Investor has received from the Issuer, and has reviewedhad the opportunity to review, such information as which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation Notes. The Investor also acknowledges that the additional risk factors set forth on Exhibit D and contained in the SEC Reports have been delivered to the Investor and recent press releases of the Issuer. The Investor acknowledges that each of has had the SEC Reports, including the opportunity to review such risk factors contained therein, are specifically incorporated herein by reference and form an integral part of this Agreementfactors.

Appears in 2 contracts

Samples: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)

Adequate Information. The Such Investor has received from the Issuer, and has reviewed, such information as the which such Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation the information set forth on Exhibit A and the SEC Reports and recent press releases of the IssuerReports. The Such Investor acknowledges that each of the SEC Reports, including the risk factors contained therein, are specifically incorporated herein by reference and form an integral part of this Agreement. Such Investor also acknowledges that the additional risk factors set forth on Exhibit A are specifically incorporated herein by reference and form an integral part of this Agreement.

Appears in 1 contract

Samples: Purchase Agreement (Path 1 Network Technologies Inc)

AutoNDA by SimpleDocs

Adequate Information. The Investor has received from the Issuer, and has reviewed, such information as which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation limitation, the SEC Reports and recent press releases of the IssuerDisclosure Documents. The Investor acknowledges that each of the SEC Reports, including Reports are specifically incorporated herein by reference and forms an integral part of this Agreement. The Investor also acknowledges that the additional risk factors set forth on Exhibit B and contained therein, in the Disclosure Documents are specifically incorporated herein by reference and form an integral part of this Agreement.

Appears in 1 contract

Samples: Form of Subscription Agreement (Eos International Inc)

Adequate Information. The Investor has received from the Issuer, and has reviewed, such information as which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation limitation, the SEC Reports and recent press releases Disclosure Schedule to this Agreement, which have been received by the Investor as part of an informational packet of materials from the IssuerIssuer (the “Disclosure Documents”). The Investor acknowledges that each of the SEC Reports, including the risk factors contained therein, are specifically incorporated herein by reference and form an integral part of this Agreement.

Appears in 1 contract

Samples: Subscription Agreement (Babyuniverse, Inc.)

Adequate Information. The Investor has received from the Issuer, and has reviewedhad the opportunity to review, such information as which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation Notes. The Investor also acknowledges that the additional risk factors set forth on Exhibit C and contained in the SEC Reports have been delivered to the Investor and recent press releases of the Issuer. The Investor acknowledges that each of has had the SEC Reports, including the opportunity to review such risk factors contained therein, are specifically incorporated herein by reference and form an integral part of this Agreementfactors.

Appears in 1 contract

Samples: Subscription Agreement (Regen Biologics Inc)

Adequate Information. The Investor has received from the Issuer, and has reviewed, such information as which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation . The Investor also acknowledges that the additional risk factors set forth on Exhibit C and contained in the SEC Reports and recent press releases of the Issuer. The Investor acknowledges that each of the SEC Reports, including the risk factors contained therein, are specifically incorporated herein by reference and form an integral part of this Agreement.

Appears in 1 contract

Samples: Subscription Agreement (Regen Biologics Inc)

Time is Money Join Law Insider Premium to draft better contracts faster.